Dec 02, 2021

Scientist in Training Awarded Grant from the Lung Cancer Research Foundation

Aria Vaishnavi, PhD, a postdoctoral fellow at Huntsman Cancer Institute is an awardee of the Lung Cancer Research Foundation 2021 Scientific Grant Program. Vaishnavi will be using this grant to better understand lung cancer caused by inhaled radon gas.

Nov 17, 2021

A Glass-Half-Full Approach to Lung Cancer in the McMahon Lab

Martin McMahon, PhD, and his research group study the genetic mutations that contribute to lung cancer. About 30% of lung cancers can now be treated based on the disease’s specific genetics. McMahon is hopeful that each subset of lung cancer will soon have its own precision treatment.

Nov 16, 2021

Can You Get Lung Cancer if You Don’t Smoke?

Even though people who smoke tobacco are at highest risk for lung cancer, non-smokers can get the disease. Learn the lung cancer risk factors for non-smokers so you can prevent lung cancer or reduce your risk.

Nov 08, 2021

Talks With Docs: Trudy Oliver, Lung Cancer Researcher

Trudy Oliver, PhD, discusses her decision to become a cancer researcher at Huntsman Cancer Institute, why researching lung cancer in so challenging and what the future holds in terms of treatments in the latest Talks with Docs.

Jun 03, 2021

Talks with Docs: Chakravarthy Reddy, Interventional Pulmonologist

Chakravarthy Reddy, MD, describes his journey to becoming a critical care doctor at Huntsman Cancer Institute, the role his mother played in helping choose this as a career and the changes he has seen in the pulmonology field during his tenure.

Mar 26, 2021

This Lung Cancer Survivor Fundraises to Give Others Hope

“I can’t tell you how intimidating it is to walk into the doctor’s office and they say those three words—‘You have cancer,’” says Pat Wasilewski. Pat found a path forward through stage IV lung cancer with the many treatment options available to him. Now he raises funds for cancer research through events like Pink Park City to give others the same hope.

Dec 07, 2020

Huntsman Cancer Institute Treats First Non-Small Cell Lung Cancer Patient on New Phase I Clinical Trial

The first patient in the world to be enrolled on a clinical trial of a new investigational drug, AN0025, was treated at Huntsman Cancer Institute at the University of Utah earlier this year. The drug is being studied for use in patients with non-small cell lung cancer and other solid tumors who have previously been treated with immunotherapy and whose cancers later developed ways to resist immunotherapy.

Nov 18, 2020

A Clinical Trial Helped This Lung Cancer Patient Breathe Easy

When Scott Vance went in for a COVID-19 test, he never expected it would lead to a diagnosis of stage IV lung cancer. Scott’s doctors learned a specific mutation was causing the cancer, and he began a new mutation-targeting drug approved by the FDA just two years earlier. Scott says his remarkable response to the drug has him feeling grateful clinical trials can bring these cutting-edge treatments to people like him.